$ Niks Prof Stocks

SGD 0.23Last Updated 22.01.2026

Issuer Rating

3/7

Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

SGD 23.52M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
SGD 0.23
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Niks Professional Ltd., together with its subsidiaries, provides family practice dermatology and aesthetic medical services under the NIKS brand in Singapore. The company operates through three segments: Clinics, Retail, and Headquarters. It offers treatment for acne and acne scars, eczema, and pigmentation, as well as non-invasive and minimally invasive aesthetic medical services, including intense pulsed...

Company Valuation

Undervalued
6/7

Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, undervalued on EV/EBITDA, underpriced on P

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks